Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenwei Yu

Showing results (81-90 of 128) with videos related to

Pageof 13
Sort By:
Drug Design, Development and Therapy|December 12, 2024
Prescribing Trends of Fixed-Dose Combination Antibiotics Not Recommended by the WHO (FNRs) for ICU Patients in Six Major Areas of China During a Seven-Year PeriodLiujun Zhou, Yuhua Zhao, Jianping Zhu, et al.
Scientific Reports|October 9, 2024
Cost-effectiveness analysis of polymyxin B versus colistin for treating patients with carbapenem-resistant gram-negative bacterial infectionsYe Wang, Lingyan Yu, Jianping Zhu, et al.
Drug Design, Development and Therapy|October 11, 2024
Population Pharmacokinetics of Tigecycline for Critically Ill Patients Undergoing Continuous Renal Replacement TherapyShuping Song, Jieqiong Liu, Wei Su, et al.
Drug Design, Development and Therapy|November 17, 2025
Population Pharmacokinetics of Tigecycline and Implications for Individualized Therapy Optimization: A Systematic ReviewAnran Dai, Feiyue Zheng, Jieqiong Liu, et al.
Frontiers in Pharmacology|February 13, 2024
Population pharmacokinetics and individualized dosing of tigecycline for critically ill patients: a prospective study with intensive samplingWei Su, Shuping Song, Jieqiong Liu, et al.
Frontiers in Aging Neuroscience|May 1, 2023
Aβ1-42-containing platelet-derived extracellular vesicle is associated with cognitive decline in Parkinson's diseaseZiyu Wang, Yuanchu Zheng, Huihui Cai, et al.
Iscience|April 15, 2021
Super-spreading on superamphiphilic micro-organized nanochannel anodic aluminum oxide surfaces for heat dissipationZhongpeng Zhu, Yupeng Chen, Zhe Xu, et al.
Journal of Neurology|December 1, 2025
Cerebrospinal fluid biomarkers for diagnosis of Parkinson's disease: a systematic review and network meta-analysisSiming Li, Chen Yang, Jiayi Wu, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 7, 2024
Detection of α-Synuclein in Oral Mucosa by Seed Amplification Assay in Synucleinopathies and Isolated REM Sleep Behavior DisorderYuanchu Zheng, Zhenwei Yu, Huihui Cai, et al.
Glia|October 29, 2021
Astrocytic VEGFA: An essential mediator in blood-brain-barrier disruption in Parkinson's diseaseGuoyu Lan, Pan Wang, Robin Barry Chan, et al.
Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
Drug Design, Development and Therapy|December 12, 2024
Prescribing Trends of Fixed-Dose Combination Antibiotics Not Recommended by the WHO (FNRs) for ICU Patients in Six Major Areas of China During a Seven-Year PeriodLiujun Zhou, Yuhua Zhao, Jianping Zhu, et al.
Scientific Reports|October 9, 2024
Cost-effectiveness analysis of polymyxin B versus colistin for treating patients with carbapenem-resistant gram-negative bacterial infectionsYe Wang, Lingyan Yu, Jianping Zhu, et al.
Drug Design, Development and Therapy|October 11, 2024
Population Pharmacokinetics of Tigecycline for Critically Ill Patients Undergoing Continuous Renal Replacement TherapyShuping Song, Jieqiong Liu, Wei Su, et al.
Drug Design, Development and Therapy|November 17, 2025
Population Pharmacokinetics of Tigecycline and Implications for Individualized Therapy Optimization: A Systematic ReviewAnran Dai, Feiyue Zheng, Jieqiong Liu, et al.
Frontiers in Pharmacology|February 13, 2024
Population pharmacokinetics and individualized dosing of tigecycline for critically ill patients: a prospective study with intensive samplingWei Su, Shuping Song, Jieqiong Liu, et al.
Frontiers in Aging Neuroscience|May 1, 2023
Aβ1-42-containing platelet-derived extracellular vesicle is associated with cognitive decline in Parkinson's diseaseZiyu Wang, Yuanchu Zheng, Huihui Cai, et al.
Iscience|April 15, 2021
Super-spreading on superamphiphilic micro-organized nanochannel anodic aluminum oxide surfaces for heat dissipationZhongpeng Zhu, Yupeng Chen, Zhe Xu, et al.
Journal of Neurology|December 1, 2025
Cerebrospinal fluid biomarkers for diagnosis of Parkinson's disease: a systematic review and network meta-analysisSiming Li, Chen Yang, Jiayi Wu, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 7, 2024
Detection of α-Synuclein in Oral Mucosa by Seed Amplification Assay in Synucleinopathies and Isolated REM Sleep Behavior DisorderYuanchu Zheng, Zhenwei Yu, Huihui Cai, et al.
Glia|October 29, 2021
Astrocytic VEGFA: An essential mediator in blood-brain-barrier disruption in Parkinson's diseaseGuoyu Lan, Pan Wang, Robin Barry Chan, et al.
Pageof 13